The importance of helix F in plasminogen activator inhibitor-1

被引:21
作者
Vleugels, N [1 ]
Gils, A [1 ]
Bijnens, AP [1 ]
Knockaert, I [1 ]
Declerck, PJ [1 ]
机构
[1] Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, B-3000 Louvain, Belgium
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 2000年 / 1476卷 / 01期
关键词
serpin; plasminogen activator inhibitor-1; mutagenesis; fibrinolysis;
D O I
10.1016/S0167-4838(99)00224-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) is the only functionally labile serpin, as it converts spontaneously into a non-reactive 'latent' conformation. Several studies have suggested an important role for helix F in the functional behavior and stability of the serpins, especially for PAI-1. We constructed a mutant of PAI-1 (PAI-1-delhF) in which residues 127-158 (hF-thFs3A) were deleted. Whereas wild-type PAI-1 (mtPAI-1) exhibits inhibitory properties towards t-PA and u-PA to an extent of 60-80% of the theoretical maximum, PAI-1-delhF did not exert any detectable inhibitory properties, but behaved as a stable substrate. Prolonged incubation at 37 degrees C did not change its functional properties in contrast to wtPAI-1 that under those conditions converts to the latent conformation. In contrast to active wtPAI-1 and other substrate-type PAI-1 mutants, PAI-1-delhF showed a 3000-fold decreased binding to vitronectin. The obtained results clearly show the importance of helix F in the inhibitory activity of PAI-1. The absence of helix F apparently leads to an impaired kinetics of insertion of the reactive site loop upon interaction with its target proteinase resulting in the inability to form a stable covalent complex. Moreover, removal of helix F strongly affects the binding of PAI-1 to vitronectin. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 43 条
[1]   Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases [J].
Aertgeerts, K ;
DeRanter, CJ ;
Booth, NA ;
Declerck, PJ .
JOURNAL OF STRUCTURAL BIOLOGY, 1997, 118 (03) :236-242
[2]   MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, CJ ;
DECLERCK, PJ .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :891-897
[3]  
AUDENAERT AM, 1994, J BIOL CHEM, V269, P19559
[4]   MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY [J].
BERKENPAS, MB ;
LAWRENCE, DA ;
GINSBURG, D .
EMBO JOURNAL, 1995, 14 (13) :2969-2977
[5]  
Carrell RW, 1996, BIOL CHEM H-S, V377, P1
[6]   CHARACTERIZATION OF COMMON NEOANTIGENIC EPITOPES GENERATED IN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AFTER CLEAVAGE OF THE REACTIVE CENTER LOOP OR AFTER COMPLEX-FORMATION WITH VARIOUS SERINE PROTEINASES [J].
DEBROCK, S ;
DECLERCK, PJ .
FEBS LETTERS, 1995, 376 (03) :243-246
[7]  
Debrock S, 1998, THROMB HAEMOSTASIS, V79, P597
[8]  
DECLERCK PJ, 1988, BLOOD, V71, P220
[9]  
DECLERCK PJ, 1992, J BIOL CHEM, V267, P11693
[10]  
DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454